BURR RIDGE, Ill. , Sept. 26, 2024 /PRNewswire/ -- SkinCure Oncology , the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the most advanced nonsurgical treatment for common skin cancer, today announced that its senior executives addressed attendees at the biennial World Cancer Congress in Geneva , emphasizing the importance of promoting fully informed decision-making by patients with cancer.
Executives also celebrated inclusion in the Union for International Cancer Control's (UICC's) "Rewriting Cancer" video series of a patient's story about her successful treatment for nonmelanoma skin cancer (NMSC) with Image-Guided SRT. SkinCure Oncology Chief Executive Officer Kerwin Brandt and Chief Innovation Officer Steven Scott spoke on the topic, "Redefining Skin Cancer: The Urgent Need for Innovation in Nonmelanoma Diagnosis and Treatment." They highlighted the growing acceptance of Image-Guided SRT, or the GentleCureTM Experience as the company calls its comprehensive suite of services, as the gold-standard of nonsurgical treatment for early-stage NMSC.
The Conference, which brings together global experts in all aspects of cancer control and spotlights the latest treatment innovations, was held September 17-19 . "The GentleCure Experience is changing the lives of those diagnosed with nonmelanoma skin cancer," Brandt said. "This is a disease affecting more than 3.
3 million individuals annually in the .
